Get startedLog in
    Picture of Biogen logo

    BIIB — Biogen News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Biogen To Pause Or Terminate Investment In Majority Of Legacy Apellis Research Programs, Says Spokesperson

    Picture of Biogen logoBiogen
    26/06/2026 12:56
    BRIEF-Biogen To Pause Or Terminate Investment In Majority Of Legacy Apellis Research Programs, Says Spokesperson
    June 26 (Reuters) - Biogen Spokesperson:
    • BIOGEN SPOKESPERSON - CONDUCTING COMPREHENSIVE REVIEW OF FORMER APELLIS CLINICAL  PRECLINICAL PORTFOLIO TO FURTHER EVALUATE STRATEGIC FIT
    • BIOGEN SPOKESPERSON: BIOGEN MADE THE DECISION TO PAUSE OR TERMINATE INVESTMENT IN THE MAJORITY OF LEGACY APELLIS RESEARCH PROGRAMS
    • BIOGEN SPOKESPERSON: A SMALL NUMBER OF ROLES WITHIN THE RESEARCH ORGANIZATION HAVE BEEN ELIMINATED

    Further company coverage: BIIB.O

     ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Biogen

    See all news